title: Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).
authors.forename: Baptiste
authors.initials: B
authors.lastname: Glace
authors.forename: Jacques-Eric
authors.initials: JE
authors.lastname: Gottenberg
authors.forename: Xavier
authors.initials: X
authors.lastname: Mariette
authors.forename: Ravaud
authors.initials: R
authors.lastname: Philippe
authors.forename: Bruno
authors.initials: B
authors.lastname: Pereira
authors.forename: Thierry
authors.initials: T
authors.lastname: Lequerré
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Berthelot
authors.forename: Maxime
authors.initials: M
authors.lastname: Dougados
authors.forename: Eric
authors.initials: E
authors.lastname: Toussirot
authors.forename: Thao
authors.initials: T
authors.lastname: Pham
authors.forename: Yannick
authors.initials: Y
authors.lastname: Allanore
authors.forename: Damien
authors.initials: D
authors.lastname: Loeuille
authors.forename: Liana
authors.initials: L
authors.lastname: Euller-Ziegler
authors.forename: Martin
authors.initials: M
authors.lastname: Soubrier
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D001323:Autoantibodies / Q000097:blood; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010456:Peptides, Cyclic / Q000276:immunology; D012042:Registries; D012217:Rheumatoid Factor / Q000032:analysis; D012218:Rheumatoid Nodule / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D001323:Autoantibodies; D010456:Peptides, Cyclic; D014409:Tumor Necrosis Factor-alpha; C487763:cyclic citrullinated peptide; D000069283:Rituximab; D012217:Rheumatoid Factor